President’s Malaria Initiative Newsletter

December 2012


Source: Maggie Hallahan Photography

A doctor cares for a sick child.
Source: Maggie Hallahan Photography

New 2013 Malaria Operational Plans

2013 Malaria Operational Plans (MOPs) for PMI are now available on the PMI website. Each of the 20 plans reviews the current status of malaria control and prevention, identifies challenges to meeting PMI goals, and describes planned activities for FY 2013.

New PMI Expansion Project in the Democratic Republic of the Congo

The new Democratic Republic of the Congo (DRC) PMI Expansion Project (PMI-EP) was recently awarded. The purpose of the PMI-EP is to assist the Government of the DRC to achieve the target of reducing malaria-associated mortality by 50 percent compared to pre-PMI levels by further expanding and scaling up malaria control interventions and reaching new geographic zones.

PMI Data Now Added to the Insecticide Resistance Mapper

The Insecticide Resistance (IR) Mapper is a tool used to view results from insecticide resistance studies (WHO susceptibility tests) using mosquitoes collected from sites throughout the world. Data from 18 of the PMI focus countries were recently added to the tool’s database.

New Malaria Diagnosis and Treatment Project Awarded: MalariaCare

MalariaCare is a new centrally funded diagnosis and treatment project that supports the expansion of high-quality diagnosis and treatment for malaria and other childhood illnesses and infectious diseases. The project’s services, which include expertise in laboratory strengthening; malaria diagnosis and treatment; and community-based management of sick children, are available to all PMI countries. During the coming year, MalariaCare will begin operating in the DRC, Ethiopia, Ghana, Guinea, Liberia, Malawi, and Zambia.

Affordable Medicines Facility – Malaria and PMI's Commitment to Global Efforts to Ensure Prompt Malaria Diagnosis and Treatment

PMI is committed to ensuring that all persons with malaria are promptly diagnosed and treated with a safe and efficacious antimalarial drug. In sub-Saharan Africa, children under 5 in impoverished, rural areas are at the greatest risk of dying from malaria and are the focus of PMI’s efforts. Subsequent to the Global Fund to Fight AIDS, Tuberculosis and Malaria Board decision in November to integrate the Affordable Medicines Facility – Malaria (AMFm) into core Global Fund grant management and financial processes, PMI remains engaged in supporting AMFm pilot countries through the transition as they incorporate support for scaling up appropriate case management in both the public and private sectors into their Global Fund grants.

Read more PMI News.

Country Activities

Stories from the Field – A Focus on Ethiopia

A malaria microscopist examines blood smears in a health center in Oromia Region, Ethiopia.
Source: Joe Malone/PMI

Read these new success stories to get a field perspective of how PMI supports key malaria prevention and treatment strategies in Ethiopia.

Enriching Communication: The Malaria Research Network of Ethiopia

Malaria is a major public health problem in Ethiopia. Seventy-five percent of the more than 80 million inhabitants there are at risk for malaria epidemics. Although significant progress has been observed in scaling up malaria control interventions over the past few years, limited efforts have been invested in using research results to inform national malaria policy and the implementation of malaria control. Learn more about what is being done to improve this process.

Improving Malaria Microscopy through Quality Assurance

Unlike in other sub-Saharan African countries, malaria in Ethiopia is caused by two malaria parasite species: Plasmodium falciparum (60 percent) and P. vivax (40 percent). Each requires a different curative drug. To ensure that patients are appropriately treated with the correct drug, it is important that patients first receive quality parasitological diagnosis.

Using Micro-planning to Accurately Quantify Needs for Antimalarial Commodities

Accurately quantifying antimalarial commodity requirements in Ethiopia is a challenge for multiple reasons. At the district level, poor quantification has often resulted in either an oversupply of antimalarial drugs and diagnostic kits and their subsequent expiry or shortages and stockouts of these commodities. Learn more about using micro-planning to help quantify needs.

Explore more Stories from the Field.

New and Updated Resources

NetWork’s Online Training Module on NetCALC Now Available

NetCALC, a new Excel-based modeling tool, is designed to model scenarios of continuous long-lasting insecticide-treated net distribution approaches based on country-specific data. It provides estimations of the ability of different channels to reach universal coverage. These channels include antenatal, immunization, and curative care clinics; schools; the community; and the retail sector.

Africa Indoor Residual Spraying Program Website Now Live

With the goals of limiting exposure to malaria and reducing incidence and prevalence of malaria, Abt Associates, through the Africa Indoor Residual Spraying (AIRS) Program, provides support and leads the implementation of indoor residual spraying activities in up to 17 PMI countries in sub-Saharan Africa.

Updated Funding Tables for FY 2012 Malaria Operational Plans

Subscribe | Unsubscribe | Update Your E-mail Address | Privacy Policy